HIV Vaccine Study Shows Modest Immune Response
Author Information
Author(s): Migueles Stephen A., Rood Julia E., Berkley Amy M., Guo Tiffany, Mendoza Daniel, Patamawenu Andy, Hallahan Claire W., Cogliano Nancy A., Frahm Nicole, Duerr Ann, McElrath M. Juliana, Connors Mark
Primary Institution: National Institute of Allergy and Infectious Diseases, National Institutes of Health
Hypothesis
Can a replication-incompetent adenovirus serotype 5 HIV vaccine induce significant cytotoxic responses in vaccinees?
Conclusion
The study found that the vaccine induced modest cytotoxic capacity in HIV-specific CD8+ T-cells, particularly in individuals with protective HLA class I alleles.
Supporting Evidence
- Vaccinees exhibited detectable HIV-specific CD8+ T-cell recall cytotoxic responses.
- Responses were significantly higher than those observed in HIV-negative controls.
- Higher cytotoxic responses were noted in vaccine recipients with protective HLA class I alleles.
Takeaway
The study tested a vaccine to see if it could help the body fight HIV, and it found that some people had a better response if they had certain genes.
Methodology
The study involved measuring HIV-specific CD8+ T-cell responses in vaccine recipients using granzyme B activity and infected CD4+ T-cell elimination assays.
Limitations
The cytotoxic responses were modest and did not correlate with the number of vaccinations or cytokine-secreting T-cell percentages.
Participant Demographics
Participants included 31 HIV-negative individuals who received 2 or 3 doses of the vaccine.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website